Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Nov-24 4:39 PM View:  | Tessari Eben Chief Operating Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 18-Nov-24 | Option Exercise | 10,000 | $1.59 | $15,900.00 | 9% 109.97K to 119.97K | |
| 20-Nov-24 4:39 PM View: | Tessari Eben Chief Operating Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 18-Nov-24 | Planned Option Sale | 10,000 | $21.04 | $210,400.00 | (8%) 119.97K to 109.97K | |
| 20-Nov-24 4:39 PM View: | Tessari Eben Chief Operating Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 18-Nov-24 | Sale (Planned) | 7,000 | $21.04 | $147,280.00 | (6%) 109.97K to 102.97K | |
| 08-Oct-24 4:14 PM View: | Baker Bros Advisors LLC Director | Kiniksa Pharmaceuticals Int... (KNSA) | 04-Oct-24 | Grant | 9,460 | -- | -- | < 1% 2.86M to 2.87M | |
| 08-Oct-24 4:40 PM View: | Megna Michael R Chief Accounting Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 04-Oct-24 | Payment of Exercise | 82 | $24.48 | $2,007.36 | (< 1%) 26.61K to 26.53K | |
| 08-Oct-24 4:40 PM View: | Megna Michael R Chief Accounting Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 04-Oct-24 | Option Exercise | 175 | -- | -- | < 1% 26.43K to 26.61K | |
| 25-Sep-24 4:39 PM View: | Tessari Eben Chief Operating Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 23-Sep-24 | Option Exercise | 10,000 | $1.59 | $15,900.00 | 8% 124.47K to 134.47K | |
| 25-Sep-24 4:39 PM View: | Tessari Eben Chief Operating Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 23-Sep-24 | Planned Option Sale | 10,000 | $24.99 | $249,900.00 | (7%) 134.47K to 124.47K | |
| 25-Sep-24 4:39 PM View: | Tessari Eben Chief Operating Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 23-Sep-24 | Sale (Planned) | 7,500 | $24.99 | $187,425.00 | (6%) 124.47K to 116.97K | |
| 04-Sep-24 8:52 PM View: | Paolini John Chief Medical Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 03-Sep-24 | Option Exercise | 60,692 | $1.88 | $113,809.00 | 117% 52.04K to 112.73K | |
| 04-Sep-24 8:42 PM View: | Moat Ross Chief Commercial Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 03-Sep-24 | Option Exercise | 68,506 | $10.95 | $750,192.00 | 315% 21.74K to 90.24K | |
| 04-Sep-24 8:52 PM View: | Paolini John Chief Medical Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 03-Sep-24 | Planned Option Sale | 60,692 | $26.12 | $1,584,990.00 | (54%) 112.73K to 52.04K | |
| 04-Sep-24 8:42 PM View: | Moat Ross Chief Commercial Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 03-Sep-24 | Planned Option Sale | 68,506 | $26.12 | $1,789,190.00 | (76%) 90.24K to 21.74K | |
| 04-Sep-24 8:53 PM View: | Tessari Eben Chief Operating Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 02-Sep-24 | Payment of Exercise | 577 | $26.74 | $15,429.00 | (< 1%) 125.05K to 124.47K | |
| 04-Sep-24 8:53 PM View: | Tessari Eben Chief Operating Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 02-Sep-24 | Option Exercise | 1,964 | -- | -- | 2% 123.09K to 125.05K | |
| 04-Sep-24 8:42 PM View: | Moat Ross Chief Commercial Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 02-Sep-24 | Option Exercise | 994 | -- | -- | 5% 21.09K to 22.08K | |
| 04-Sep-24 8:52 PM View: | Paolini John Chief Medical Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 02-Sep-24 | Payment of Exercise | 835 | $26.74 | $22,327.90 | (2%) 52.87K to 52.04K | |
| 04-Sep-24 8:55 PM View: | Patel Sanj K Chairman & CEO Director | Kiniksa Pharmaceuticals Int... (KNSA) | 02-Sep-24 | Payment of Exercise | 3,177 | $26.74 | $84,953.00 | (2%) 192.52K to 189.35K | |
| 04-Sep-24 8:51 PM View: | Ragosa Mark Chief Financial Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 02-Sep-24 | Option Exercise | 1,861 | -- | -- | 8% 22.05K to 23.91K | |
| 04-Sep-24 8:57 PM View: | Megna Michael R Chief Accounting Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 02-Sep-24 | Payment of Exercise | 329 | $26.74 | $8,797.46 | (1%) 26.76K to 26.43K | |
| 04-Sep-24 8:57 PM View: | Megna Michael R Chief Accounting Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 02-Sep-24 | Option Exercise | 775 | -- | -- | 3% 25.99K to 26.76K | |
| 04-Sep-24 8:42 PM View: | Moat Ross Chief Commercial Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 02-Sep-24 | Payment of Exercise | 345 | $26.74 | $9,225.30 | (2%) 22.08K to 21.74K | |
| 04-Sep-24 8:51 PM View: | Ragosa Mark Chief Financial Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 02-Sep-24 | Payment of Exercise | 956 | $26.74 | $25,563.40 | (4%) 23.91K to 22.96K | |
| 04-Sep-24 8:52 PM View: | Paolini John Chief Medical Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 02-Sep-24 | Option Exercise | 1,725 | -- | -- | 3% 51.15K to 52.87K | |
| 04-Sep-24 8:55 PM View: | Patel Sanj K Chairman & CEO Director | Kiniksa Pharmaceuticals Int... (KNSA) | 02-Sep-24 | Option Exercise | 6,569 | -- | -- | 4% 185.95K to 192.52K | |
| 04-Sep-24 8:42 PM View: | Moat Ross Chief Commercial Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 01-Sep-24 | Payment of Exercise | 1,393 | $26.74 | $37,248.80 | (6%) 22.48K to 21.09K | |
| 04-Sep-24 8:51 PM View: | Ragosa Mark Chief Financial Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 01-Sep-24 | Payment of Exercise | 2,260 | $26.74 | $60,432.40 | (9%) 24.31K to 22.05K | |
| 04-Sep-24 8:52 PM View: | Paolini John Chief Medical Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 01-Sep-24 | Option Exercise | 4,121 | -- | -- | 8% 49.02K to 53.14K | |
| 04-Sep-24 8:55 PM View: | Patel Sanj K Chairman & CEO Director | Kiniksa Pharmaceuticals Int... (KNSA) | 01-Sep-24 | Option Exercise | 16,474 | -- | -- | 9% 177.45K to 193.92K | |
| 04-Sep-24 8:53 PM View: | Tessari Eben Chief Operating Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 01-Sep-24 | Payment of Exercise | 1,322 | $26.74 | $35,350.30 | (1%) 124.41K to 123.09K | |
| 04-Sep-24 8:53 PM View: | Tessari Eben Chief Operating Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 01-Sep-24 | Option Exercise | 4,499 | -- | -- | 4% 119.91K to 124.41K | |
| 04-Sep-24 8:42 PM View: | Moat Ross Chief Commercial Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 01-Sep-24 | Option Exercise | 4,089 | -- | -- | 22% 18.39K to 22.48K | |
| 04-Sep-24 8:52 PM View: | Paolini John Chief Medical Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 01-Sep-24 | Payment of Exercise | 1,994 | $26.74 | $53,319.60 | (4%) 53.14K to 51.15K | |
| 04-Sep-24 8:55 PM View: | Patel Sanj K Chairman & CEO Director | Kiniksa Pharmaceuticals Int... (KNSA) | 01-Sep-24 | Payment of Exercise | 7,967 | $26.74 | $213,038.00 | (4%) 193.92K to 185.95K | |
| 04-Sep-24 8:51 PM View: | Ragosa Mark Chief Financial Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 01-Sep-24 | Option Exercise | 4,444 | -- | -- | 22% 19.87K to 24.31K | |
| 04-Sep-24 8:57 PM View: | Megna Michael R Chief Accounting Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 01-Sep-24 | Payment of Exercise | 2,755 | $26.74 | $73,668.70 | (10%) 28.74K to 25.99K | |
| 04-Sep-24 8:57 PM View: | Megna Michael R Chief Accounting Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 01-Sep-24 | Option Exercise | 6,490 | -- | -- | 29% 22.25K to 28.74K | |
| 29-Aug-24 4:36 PM View: | Tessari Eben Chief Operating Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 27-Aug-24 | Sale (Planned) | 7,500 | $26.91 | $201,825.00 | (6%) 127.41K to 119.91K | |
| 29-Aug-24 4:36 PM View: | Tessari Eben Chief Operating Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 27-Aug-24 | Option Exercise | 10,000 | $1.59 | $15,900.00 | 8% 127.41K to 137.41K | |
| 29-Aug-24 4:36 PM View: | Tessari Eben Chief Operating Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 27-Aug-24 | Planned Option Sale | 10,000 | $26.91 | $269,100.00 | (7%) 137.41K to 127.41K | |
| 25-Jul-24 4:31 PM View: | Paolini John Chief Medical Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 23-Jul-24 | Option Exercise | 22,000 | $1.86 | $40,920.00 | 46% 47.8K to 69.8K | |
| 25-Jul-24 4:33 PM View: | Patel Sanj K Chairman & CEO Director | Kiniksa Pharmaceuticals Int... (KNSA) | 23-Jul-24 | Option Exercise | 136,124 | $1.59 | $216,437.00 | 79% 172.81K to 308.93K | |
| 25-Jul-24 4:31 PM View: | Paolini John Chief Medical Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 23-Jul-24 | Planned Option Sale | 22,000 | $26.32 | $578,966.00 | (32%) 69.8K to 47.8K | |
| 25-Jul-24 4:33 PM View: | Patel Sanj K Chairman & CEO Director | Kiniksa Pharmaceuticals Int... (KNSA) | 23-Jul-24 | Planned Option Sale | 136,124 | $25.65 | $3,491,950.00 | (44%) 308.93K to 172.81K | |
| 25-Jul-24 4:32 PM View: | Ragosa Mark Chief Financial Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 23-Jul-24 | Option Exercise | 24,248 | $11.10 | $269,153.00 | 126% 19.25K to 43.5K | < 1% |
| 25-Jul-24 4:32 PM View: | Ragosa Mark Chief Financial Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 23-Jul-24 | Planned Private Option Sale | 24,248 | $24.79 | $601,108.00 | (56%) 43.5K to 19.25K | |
| 04-Sep-24 8:57 PM View: | Megna Michael R Chief Accounting Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 15-Jul-24 | Grant | 480 | $15.65 | $7,512.00 | 2% 21.77K to 22.25K | |
| 04-Sep-24 8:42 PM View: | Moat Ross Chief Commercial Officer | Kiniksa Pharmaceuticals Int... (KNSA) | 15-Jul-24 | Grant | 211 | $15.65 | $3,302.15 | 1% 18.18K to 18.39K | |
| 07-Jun-24 4:36 PM View: | Popovits Kimberly J Director | Kiniksa Pharmaceuticals Int... (KNSA) | 06-Jun-24 | Option Exercise | 4,373 | -- | -- | 87% 5.0K to 9.37K | |
| 07-Jun-24 4:41 PM View: | Cole G Bradley Director | Kiniksa Pharmaceuticals Int... (KNSA) | 06-Jun-24 | Option Exercise | 4,373 | -- | -- | 87% 5.0K to 9.37K |
